National Psoriasis Foundation Incorporated Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • National Psoriasis Foundation Incorporated's estimated annual revenue is currently $34.3M per year.(i)
  • National Psoriasis Foundation Incorporated's estimated revenue per employee is $270,000

Employee Data

  • National Psoriasis Foundation Incorporated has 127 Employees.(i)
  • National Psoriasis Foundation Incorporated grew their employee count by -1% last year.

National Psoriasis Foundation Incorporated's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
VP Finance and OperationsReveal Email/Phone
3
VP, Field Development & OperationsReveal Email/Phone
4
VP, Government Relations and AdvocacyReveal Email/Phone
5
Associate Director, Corporate RelationsReveal Email/Phone
6
Chief Scientific & Medical OfficerReveal Email/Phone
7
Director ResearchReveal Email/Phone
8
Chief Revenue Officer (CRO)Reveal Email/Phone
9
Chief Scientific & Medical OfficerReveal Email/Phone
10
Director, Marketing & CommunicationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$382.1M40627%$850M$1.2B
Add Company

What Is National Psoriasis Foundation Incorporated?

Non-Profit & Professional Orgs.

keywords:N/A

N/A

Total Funding

127

Number of Employees

$34.3M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

National Psoriasis Foundation Incorporated News

2022-04-06 - Cubosomal betamethasone-salicylic acid nano drug delivery | IJN

Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol.

2022-03-22 - New Data Show Majority of Adults with Moderate to Severe Plaque ...

Comorbidities in Patients with Psoriatic Arthritis. Rambam Maimonides Med J. 2017;8(1):e0004. 27. National Psoriasis Foundation. About Psoriatic...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A127-22%N/A
#2
$50.8M1276%N/A
#3
$3.5M1276%N/A
#4
$36.8M1272%N/A
#5
N/A12720%N/A